Drug Interaction Report

Buprenorphine and Flavoxate: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Flavoxate

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 633 documented Buprenorphine interactions, 601 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Taking buprenorphine with flavoxate can add up to cause severe constipation or trouble urinating, so watch for a bloated belly, no bowel movements, or difficulty peeing and tell your care team. This is a theoretical risk that can be managed with monitoring and a bowel plan.

Both of these medicines can slow down your gut and make it harder to pee. Buprenorphine is an opioid, and opioids are well known for causing constipation. Flavoxate relaxes the bladder muscle and has drying (anticholinergic) effects that can also slow the bowels and the bladder. When you take them together, those effects can add up.

In rare cases, this could lead to severe constipation where the gut nearly stops moving (called paralytic ileus), or trouble emptying your bladder. This is a theoretical concern, not something proven to happen often. The good news is your care team can watch for it and manage it. Keep taking both as prescribed and let them know if you notice problems.

Effect: Additive reduction in GI and urinary motility, with a theoretical increased risk of paralytic ileus and urinary retention when buprenorphine (opioid) is combined with flavoxate (anticholinergic/antimuscarinic).

Mechanism: Additive effects on gut motility. Opioid-induced constipation plus antimuscarinic slowing of smooth muscle.

  • Direction: Pharmacodynamic (additive), not a metabolic/prodrug issue.
  • Evidence: Theoretical; severity rated major.
  • Onset: Unspecified.
  • Management: Monitor for constipation, abdominal distension, absent bowel sounds, and urinary retention. Ensure bowel regimen; consider dose review or alternative if symptoms emerge.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of paralytic ileus

Interaction Deep Dive

When buprenorphine is given together with an anticholinergic agent, the combination can lead to urinary retention or severe constipation that progresses to paralytic ileus. Watch for indications of urinary retention or diminished gastric motility in patients receiving buprenorphine alongside anticholinergic medications1.

Why it happens (mechanism)

Additive effects on gastric motility

How to manage this interaction

Your care team can manage this combination safely with a few practical steps:

  • Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
  • Watch for severe or worsening constipation, a bloated or painful belly, no bowel movements, nausea or vomiting, and trouble urinating.
  • Your team may monitor you more closely, suggest a bowel regimen (fluids, fiber, or a stool softener/laxative if appropriate), or adjust and individualize your doses.

Contact your pharmacist or prescriber promptly if you notice these symptoms, and seek urgent care if you cannot pass stool or urine.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Buprenorphine and Flavoxate together?

Taking buprenorphine with flavoxate can add up to cause severe constipation or trouble urinating, so watch for a bloated belly, no bowel movements, or difficulty peeing and tell your care team. This is a theoretical risk that can be managed with monitoring and a bowel plan. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Buprenorphine and Flavoxate interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Buprenorphine and Flavoxate interaction managed?

Your care team can manage this combination safely with a few practical steps: Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Watch for severe or worsening constipation, a bloated or painful belly, no bowel movements, nausea or vomiting, and trouble urinating. Your team may monitor you more closely, suggest a bowel regimen (fluids, fiber, or a stool softener/la… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Buprenorphine or Flavoxate need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.